public investment is anticipated to grow at the lower rate compared to last year due to the delay of extra-budget disbursement. For internal stability, headline inflation is predicted to reach 0.7 percent
, diversified and steady cash flows making it a unique world-class chemical company. This acquisition will be funded by cash and debt and there is no equity dilution anticipated. IVL balance sheet was
leading to margin increase in all commodity products, supporting the increase in crude oil prices. All of this is translating into stronger than anticipated earnings in first half 2021. Transformation
are not a guarantee of future performance. 2019 and 2021 projections are based on historical 2017-2018 performance and management forecast. The predicted volume is based on legacy and new assets already
historical 2017-2018 performance and management forecast. The predicted volume is based on legacy and new assets already committed, planned and announced. Such forward-looking statements speak only as at the
2021 projections are based on historical 2017-2018 performance and management forecast. The predicted volume is based on legacy and new assets already committed, planned and announced. Such forward
(PAC) is issued under the CFP, which is anticipated to be in the third quarter of 2023. Moreover, the company will enter into other relevant agreements, i.e. the Asset Sale and Purchase Agreement, the
and management forecast. The predicted volume is based on legacy and new assets already committed, planned and announced. Such forward-looking statements speak only as at the date of this document, and